Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
EPA CPDat observed this chemical in 229 composition records across product categories including Construction and building materials, Home maintenance, Specialty occupational products.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 (low) · high confidence.
Prevalence of ETHYLCELLULOSE in our catalog (epa_cpdat).
Products
229
Brands
6
Typical roles
Catalog
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 229 composition records across product categories including Construction and building materials, Home maintenance, Specialty occupational products. EPA CPDat classifies this chemical for functional uses including Film former, Viscosity modifier, Binder.
US
FDA
APOKRA Breastfeeding Vegan
Apokra
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 153 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION, EXTENDED RELEASE; Potency: NA
US
FDA
Route: ORAL; Dosage form: POWDER; Maximum daily exposure: 2090 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Potency: NA
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: NA
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 300 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 20 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 53.8 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 1120 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 83 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Potency: 52.5 mg
US
FDA
Route: TOPICAL; Dosage form: SYSTEM; Maximum daily exposure: 10 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 701 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 1754 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 583 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 1875 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Potency: 35.28 mg
US
FDA
Route: TRANSDERMAL; Dosage form: FILM, EXTENDED RELEASE; Potency: 80.4 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 880 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 106 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 1323 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Maximum daily exposure: 36 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 882 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 1538 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 1547 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 110 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 50 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 4 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 42 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 45 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 81 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 1014 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 50 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 48 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 715 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 1259 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 4 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 158 mg
US
FDA
Route: TOPICAL; Dosage form: SYSTEM; Maximum daily exposure: 72 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 62 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 1092 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 177 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 1133 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 15 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 81 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 140 mg
US
FDA
openFDA substance registry classifies this ingredient as polymer.
US
FDA
openFDA substance registry classifies this ingredient as concept.
US
FDA
openFDA substance registry classifies this ingredient as mixture.